Perioral Tissue Evaluation With Advanced Videodermoscopy (FAV)
NCT ID: NCT06732609
Last Updated: 2024-12-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
80 participants
OBSERVATIONAL
2024-01-08
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We chose a sample of 40 participants to improve the reliability of variability estimates for key outcomes, such as perioral skin characteristics, which are essential for informing future larger-scale studies. This sample size also allows for the assessment of the methodology's feasibility across a more heterogeneous group, enhancing the generalizability of the results.
The Horus 1000VMF system used in this study consists of two lightweight probes (approximately 195 grams each) with a contact lens diameter of 2 cm. These probes are designed for dermatoscopic analysis and are equipped with two magnifications:
30x magnification, which provides a field of view (FOV) of 41.07 mm². 150x magnification, offering a FOV of 2.168 mm². The system's software allows for toggling between polarized and white light modes for enhanced observation. The focus of the images is controlled manually for precision in capturing details.
The FAV probe (Fluorescence Advanced Videodermatoscopy) enables imaging at a magnification of 500x, with a FOV of 0.092 mm². This probe utilizes a monochromatic light source with a wavelength of 405 nm to visualize layers of the skin in vivo that typically require biopsy and histological analysis.
For each patient, three anatomical areas of interest were identified and evaluated: the Anterior Chin Area (ACA), The transition zone between the ACA and the labial integument, also known as the Vermilion Border (VB), And the pigmented area of the lip, also known as the Vermilion Zone (VZ). Prior to image acquisition, the perioral region was prepared by cleaning the skin to remove any external residues, such as cosmetics or skincare products, that could affect image quality. When using the FAV mode, glycerol was applied to the skin surface to minimize light scattering and enhance image clarity. . Initially, macro images were acquired to capture a broader view of the region. Following this, a specific sequence was followed for the detailed analysis.
This sequential approach ensured a comprehensive evaluation of both surface and deeper skin structures across the different regions of interest. Once the images were captured, they were stored in the system's dedicated software for further analysis. This allowed the images to be saved and compared to future scans or used for diagnostic purposes.
The acquired dermatoscopic and FAV images were carefully reviewed by two independent investigators, both experienced in using the Horus 1000VMF system for clinical evaluations. The review process was conducted in a blinded manner, without knowledge of the patients' clinical characteristics, to avoid bias. In cases where there was a discrepancy between the two evaluators, a third evaluator was consulted to reach a consensus on the final interpretation of the images.
Others key parameters included age, sex, skin type based on Baumann's classification (Baumann, L. 2006), and Fitzpatrick's phototype (Fitzpatrick, T. B. 1988) classification were considered. Baumann's classification categorizes skin into four main types (normal, oily, dry, and combination). Fitzpatrick's classification, on the other hand, divides skin into six phototypes (I to VI) based on the skin's response to ultraviolet (UV) radiation, ranging from phototype I (very fair skin, always burns, never tans) to phototype VI (dark skin, never burns, deeply pigmented). These complementary systems provided a detailed characterization of the study population.
Descriptive statistics, such as means, medians, ranges, and relative frequencies, were employed to characterize the study participants and analyze the dermatoscopic and FAV findings.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Health Status: Participants must be in good general health with no known systemic diseases (ASA I)
* Skin Condition: Participants must have clinically healthy skin in the target area, with no history of dermatological conditions such as eczema, psoriasis, or dermatitis
* Consent: Participants must provide written informed consent to participate in the study
* Non-Smoking: Participants should be non-smokers or have quit smoking for at least 12 months
* Exposure: Must not have been recently exposed to treatments affecting the skin in the area of interest (e.g., laser treatments, chemical peels, or topical medications) within the last 3 months
Exclusion Criteria
* Chronic Illnesses: Presence of chronic systemic conditions (e.g., diabetes, autoimmune diseases) that may affect skin health
* Medications: Current use of medications or treatments that could alter skin characteristics (e.g., corticosteroids, retinoids, immunosuppressants)
* Allergies: Known allergies to topical products used during the examination
* Pregnancy or Lactation: Pregnant or breastfeeding individuals are excluded due to potential skin changes during these periods
* Recent Skin Procedures: Any recent dermatological procedures (e.g., laser therapy, chemical peels) performed within the last 3 months in the area of evaluation
* Excessive Sun Exposure: Individuals with recent excessive sun exposure or sunburns in the target area within the last 2 months
* Non-Compliance: Individuals unwilling or unable to comply with the study procedures
20 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Massimo Cordaro, MD
Role: PRINCIPAL_INVESTIGATOR
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UOC Clinica Odontoiatrica, Fondazione Policlinico Agostino Gemelli IRCCS
Roma, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Massimo Cordaro, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988 Jun;124(6):869-71. doi: 10.1001/archderm.124.6.869. No abstract available.
Browne RH. On the use of a pilot sample for sample size determination. Stat Med. 1995 Sep 15;14(17):1933-40. doi: 10.1002/sim.4780141709.
Gupta V, Sharma VK. Skin typing: Fitzpatrick grading and others. Clin Dermatol. 2019 Sep-Oct;37(5):430-436. doi: 10.1016/j.clindermatol.2019.07.010. Epub 2019 Jul 17.
Soglia S, Perez-Anker J, Lobos Guede N, Giavedoni P, Puig S, Malvehy J. Diagnostics Using Non-Invasive Technologies in Dermatological Oncology. Cancers (Basel). 2022 Nov 29;14(23):5886. doi: 10.3390/cancers14235886.
Sanlorenzo M, Vujic I, De Giorgi V, Tomasini C, Deboli T, Quaglino P, Fierro MT, Broganelli P. Fluorescence-advanced videodermatoscopy: a new method for in vivo skin evaluation. Br J Dermatol. 2017 Nov;177(5):e209-e210. doi: 10.1111/bjd.15594. Epub 2017 Oct 27. No abstract available.
Argenziano G, Soyer HP. Dermoscopy of pigmented skin lesions--a valuable tool for early diagnosis of melanoma. Lancet Oncol. 2001 Jul;2(7):443-9. doi: 10.1016/s1470-2045(00)00422-8.
Gonzalez S, Tannous Z. Real-time, in vivo confocal reflectance microscopy of basal cell carcinoma. J Am Acad Dermatol. 2002 Dec;47(6):869-74. doi: 10.1067/mjd.2002.124690.
Abati S, Bramati C, Bondi S, Lissoni A, Trimarchi M. Oral Cancer and Precancer: A Narrative Review on the Relevance of Early Diagnosis. Int J Environ Res Public Health. 2020 Dec 8;17(24):9160. doi: 10.3390/ijerph17249160.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3318
Identifier Type: -
Identifier Source: org_study_id